Shane Blackmon
Contributor since: 2012
Latest Articles
This Under-The-Radar Diabetes Stock Has Significant Upside Potential
J.C. Penney Debt Looks Intriguing -- Still Too Early To Buy Equity
Quicksilver Resources: Making Promising Moves In The Right Direction
Chelsea Therapeutics: A Shoe-In For FDA Approval, Shares Could Double From Here
Cogo Group: An Interesting Special Situation Stock
PDL BioPharma Shares Look Ready To Tumble
Closed-End Funds Trading At Premiums To NAV Are Seeing Their Bubbles Burst
Simple Math Showing Why Synergy Pharmaceuticals Is Undervalued
Whiting USA Trust I: Investors Continue To Overpay For This Trust
Clearwire: Is The Rally Over?
The Stars Are Aligning For This Retailer
Jamba: Earnings, A Disappointment
American International Group: Secondary Coming, Wait To Buy
How To Trade Amarin After The FDA Decision
You'll Lose 50% Of Your Money If You Hold This Trust For The Next 3 Years
BP Prudhoe Bay Royalty Trust: This Trust Is Worth 50% Of Today's Price
Time To Get Rid Of This Natural Gas Stock
Ford: Still Stuck In Low Gear
DryShips: Ready To Sail Higher This Summer
This Misunderstood Retailer Is Ready To Double By Year End
Sell Arena Pharmaceuticals And Step To The Sidelines
Gold Will Have A Rough Week Ahead
Massive Buyback Announced At JA Solar
Sizeable Insider Buying In Bank Of America
This Hotel REIT Looks Set For A Turnaround
This Lumber Stock Is Building A Turnaround
This Tire Maker Is Ready To Roll In The Profits
Massive Insider Buying At McDermott International
CEO Keeps Buying Shares Of This 6%+ Dividend Yielder
3D Printing: Why Hewlett-Packard Must Make An Acquisition
Pacific Sunwear: Significant Insider Buying Might Signal A Turnaround
Cirrus Logic: Take A Bite Out Of This Apple Supplier